Search Results - "Bucsics, Anna"

Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study by Tian, Yuxi, Reichardt, Berthold, Dunkler, Daniela, Hronsky, Milan, Winkelmayer, Wolfgang C., Bucsics, Anna, Strohmaier, Susanne, Heinze, Georg

“…Generic medications offer substantial potential cost savings to health systems compared to their branded counterparts. In Europe and the US, they are only…”
Get full text

Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA by Cavaller-Bellaubi, Maria, Hughes-Wilson, Wills, Kubinová, Šárka, Van de Casteele, Marc, Van Lente, Evert Jan, Degortes, Emanuele, Pontén, Johan, Eichler, Hans-Georg, Le Cam, Yann, Boselli, Simone, Bucsics, Anna

“…The Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) was established in 2013 with the intention of developing a coordinated mechanism…”
Get full text

The European challenges of funding orphan medicinal products by Szegedi, Márta, Zelei, Tamás, Arickx, Francis, Bucsics, Anna, Cohn-Zanchetta, Emanuelle, Fürst, Jurij, Kamusheva, Maria, Kawalec, Pawel, Petrova, Guenka, Slaby, Juraj, Stawowczyk, Ewa, Vocelka, Milan, Zechmeister-Koss, Ingrid, Kaló, Zoltán, Molnár, Mária Judit

“…Funding of orphan medicinal products (OMPs) is an increasing challenge in the European Union (EU). To identify the different methods for public funding of OMPs…”
Get full text

Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria by Kossmeier, Michael, Themanns, Madeleine, Hatapoglu, Lena, Kogler, Bernhard, Keuerleber, Simon, Lichtenecker, Jutta, Sauermann, Robert, Bucsics, Anna, Freissmuth, Michael, Zebedin-Brandl, Eva

“…Objectives: Reimbursement decisions on new medicines require an assessment of their value. In Austria, when applying for reimbursement of new medicines,…”
Get full text

Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries by Wilking, Nils, Bucsics, Anna, Kandolf Sekulovic, Lidlija, Kobelt, Gisela, Laslop, Andrea, Makaroff, Lydia, Roediger, Alexander, Zielinski, Christoph

“…The Central European Cooperative Oncology Group (CECOG) and ‘ESMO Open—Cancer Horizons’ roundtable discussion brought together stakeholders from several…”
Get full text

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways by Ermisch, Michael, Bucsics, Anna, Vella Bonanno, Patricia, Arickx, Francis, Bybau, Alexander, Bochenek, Tomasz, van de Casteele, Marc, Diogene, Eduardo, Fürst, Jurij, Garuolienė, Kristina, van der Graaff, Martin, Gulbinovič, Jolanta, Haycox, Alan, Jones, Jan, Joppi, Roberta, Laius, Ott, Langner, Irene, Martin, Antony P, Markovic-Pekovic, Vanda, McCullagh, Laura, Magnusson, Einar, Nilsen, Ellen, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Sauermann, Robert, Schuurman, Ad, Ramos, Ricardo, Vlahovic-Palcevski, Vera, Zara, Corinne, Godman, Brian

“…Payers are a major stakeholder in any considerations and initiatives concerning adaptive licensing of new medicinal products, also referred to as Medicines…”
Get full text

e‐SPC – delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers by Maxwell, Simon, Eichler, Hans‐Georg, Bucsics, Anna, Haefeli, Walter E., Gustafsson, Lars L.

Get full text

Use of Recommended Medications after Myocardial Infarction in Austria by Winkelmayer, Wolfgang C., Bucsics, Anna E., Schautzer, Alexandra, Wieninger, Peter, Pogantsch, Michaela

“…Guidelines recommend long-term use of betablockers (BB), statins, and angiotensin-converting-enzymeinhibitors or angiotensin-receptor-blockers (ACEI/ARB) after…”
Get full text

HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries by Nicod, Elena, Annemans, Lieven, Bucsics, Anna, Lee, Anne, Upadhyaya, Sheela, Facey, Karen

“…Highlights • OMPs are often cost-ineffective and their value is characterised by greater uncertainty. • New EU/national HTA programmes for (ultra-)OMPs aim to…”
Get full text

Wie kann der Zugang zu „orphan drugs“ verbessert werden?: Erfahrungen aus einer europäischen Kooperation by Bucsics, Anna

“…Zusammenfassung Die europäische Arzneimittelgesetzgebung ist, was die Entwicklung neuer Medikamente für seltene Erkrankungen betrifft, ein Erfolg. Allerdings…”
Get full text

The evolution of adaptiveness: balancing speed and evidence by Eichler, Hans-Georg, Barker, Richard, Bedlington, Nicola, Bouvy, Jacoline C., Broekmans, André W., Bucsics, Anna, Cerreta, Francesca, Corriol-Rohou, Solange, Granados, Alicia, Le Cam, Yann, Schuurman, Ad

“…'Adaptive' approaches to bringing drugs to market have been widely discussed in recent years. Here, we describe the evolution of the adaptive approach and of…”
Get full text

LOOKING BACK ON 5 YEARS OF HORIZON SCANNING IN ONCOLOGY by Nachtnebel, Anna, Breuer, Johanna, Willenbacher, Wolfgang, Bucsics, Anna, Krippl, Peter, Wild, Claudia

“…The regularly structured adaptation of health technology assessment (HTA) programs is of utmost importance to sustain the relevance of the products for…”
Get more information

The use of TNF-inhibitors in ankylosing spondylitis in Austria from 2007 to 2009 - a retrospective analysis by Nell-Duxneuner, Valerie, Schroeder, Yvonne, Reichardt, Berthold, Bucsics, Anna

“…The introduction of anti- tumor necrosis factor-alpha agents (TNF-inhibitors) offered new dimensions in symptom relief and alteration of disease progression…”
Get full text

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA by Vella Bonanno, Patricia, Bucsics, Anna, Simoens, Steven, Martin, Antony P, Oortwijn, Wija, Gulbinovič, Jolanta, Rothe, Celia, Timoney, Angela, Ferrario, Alessandra, Gad, Mohamed, Salem, Ahmed, Hoxha, Iris, Sauermann, Robert, Kamusheva, Maria, Dimitrova, Maria, Petrova, Guenka, Laius, Ott, Selke, Gisbert, Kourafalos, Vasilios, Yfantopoulos, John, Magnusson, Einar, Joppi, Roberta, Jakupi, Arianit, Bochenek, Tomasz, Wladysiuk, Magdalene, Furtado, Claudia, Marković-Peković, Vanda, Mardare, Ileana, Meshkov, Dmitry, Fürst, Jurij, Tomek, Dominik, Cortadellas, Merce Obach, Zara, Corrine, Haycox, Alan, Campbell, Stephen, Godman, Brian

“…In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health…”
Get more information

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications by Godman, Brian, Wettermark, Bjorn, van Woerkom, Menno, Fraeyman, Jessica, Alvarez-Madrazo, Samantha, Berg, Christian, Bishop, Iain, Bucsics, Anna, Campbell, Stephen, Finlayson, Alexander E, Fürst, Jurij, Garuoliene, Kristina, Herholz, Harald, Kalaba, Marija, Laius, Ott, Piessnegger, Jutta, Sermet, Catherine, Schwabe, Ulrich, Vlahović-Palčevski, Vera V, Markovic-Pekovic, Vanda, Vončina, Luka, Malinowska, Kamila, Zara, Corinne, Gustafsson, Lars L

“…The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilization…”
Get full text

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? by Godman, Brian, Malmström, Rickard E, Diogene, Eduardo, Gray, Andy, Jayathissa, Sisira, Timoney, Angela, Acurcio, Francisco, Alkan, Ali, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen M, Czeczot, Jadwiga, de Bruyn, Winnie, Eriksson, Irene, Yusof, Faridah Aryani Md, Finlayson, Alexander E, Fürst, Jurij, Garuoliene, Kristina, Guerra Júnior, Augusto, Gulbinovič, Jolanta, Jan, Saira, Joppi, Roberta, Kalaba, Marija, Magnisson, Einar, McCullagh, Laura, Miikkulainen, Kaisa, Ofierska-Sujkowska, Gabriela, Pedersen, Hanne Bak, Selke, Gisbert, Sermet, Catherine, Spillane, Susan, Supian, Azuwana, Truter, Ilse, Vlahović-Palčevski, Vera, Vien, Low Ee, Vural, Elif H, Wale, Janet, Władysiuk, Magdałene, Zeng, Wenjie, Gustafsson, Lars L

“…Medicines have made an appreciable contribution to improving health. However, even high-income countries are struggling to fund new premium-priced medicines…”
Get more information

Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study: Prevalence of double medication by Heinze, Georg, Jandeck, Lisanne M., Hronsky, Milan, Reichardt, Berthold, Baumgärtel, Christoph, Bucsics, Anna, Müllner, Marcus, Winkelmayer, Wolfgang C.

Get full text

Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study by Heinze, Georg, Jandeck, Lisanne M., Hronsky, Milan, Reichardt, Berthold, Baumgärtel, Christoph, Bucsics, Anna, Müllner, Marcus, Winkelmayer, Wolfgang C.

“…Purpose Double medication is defined as the unintended overlapping prescription of two identical substances with the same route of administration by two…”
Get full text

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways by Ermisch, M, Bucsics, A, Bonanno, PV, Arickx, F, Bybau, A, Bochenek, T, van de Casteele, M, Diogene, E, Furst, J, Garuoliene, K, van der Graaff, M, Gulbinovic, J, Haycox, A, Jones, J, Joppi, R, Laius, O, Langner, I, Martin, AP, Markovic-Pekovic, V, McCullagh, L, Magnusson, E, Nilsen, E, Selke, G, Sermet, C, Simoens, S, Sauermann, R, Schuurman, A, Ramos, R, Vlahovic-Palcevski, V, Zara, C, Godman, B

Get full text

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications by Godman, Brian, Petzold, Max, Bennett, Kathleen, Bennie, Marion, Bucsics, Anna, Finlayson, Alexander E, Martin, Andrew, Persson, Marie, Piessnegger, Jutta, Raschi, Emanuel, Simoens, Steven, Zara, Corinne, Barbui, Corrado

“…Generic atypical antipsychotic drugs offer health authorities opportunities for considerable savings. However, schizophrenia and bipolar disorders are complex…”
Get full text